Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Mylan Pharmaceuticals Inc., A Viatris Company with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-6860-77
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.